about
Impaired glucose homeostasis in transgenic mice expressing the human transient neonatal diabetes mellitus locus, TNDMThe APJ receptor: a new therapeutic approach in diabetic treatmentCentral chronic apelin infusion decreases energy expenditure and thermogenesis in mice.How gut microbes talk to organs: The role of endocrine and nervous routesApelin stimulates glucose utilization in normal and obese insulin-resistant miceInvolvement of NPY Y2 receptor subtype in the control of the spontaneous NO/GnRH release at the rat median eminenceVentromedial hypothalamic nitric oxide production is necessary for hypoglycemia detection and counterregulationCannabinoid CB2 receptor potentiates obesity-associated inflammation, insulin resistance and hepatic steatosisSelective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia.Drosophila genome-wide obesity screen reveals hedgehog as a determinant of brown versus white adipose cell fate.Deletion of Lkb1 in pro-opiomelanocortin neurons impairs peripheral glucose homeostasis in miceGut microbiota controls adipose tissue expansion, gut barrier and glucose metabolism: novel insights into molecular targets and interventions using prebiotics.The uterine and vascular actions of estetrol delineate a distinctive profile of estrogen receptor α modulation, uncoupling nuclear and membrane activation.Altered gut microbiota and endocannabinoid system tone in obese and diabetic leptin-resistant mice: impact on apelin regulation in adipose tissue.Impact of hypothalamic reactive oxygen species in the regulation of energy metabolism and food intakeApelin regulates FoxO3 translocation to mediate cardioprotective responses to myocardial injury and obesity.Glucosensing in the gastrointestinal tract: Impact on glucose metabolism.Role of central nervous system glucagon-like Peptide-1 receptors in enteric glucose sensingPancreatic alpha-cell dysfunction in diabetes.Hypothalamic apelin/reactive oxygen species signaling controls hepatic glucose metabolism in the onset of diabetes.Apelin targets gut contraction to control glucose metabolism via the brain.Transfer of dysbiotic gut microbiota has beneficial effects on host liver metabolism.Apelin, diabetes, and obesity.Apelin, a promising target for type 2 diabetes treatment?Hypothalamic actions of apelin on energy metabolism: new insight on glucose homeostasis and metabolic disorders.Apelin receptors: From signaling to antidiabetic strategy.Mitochondrial Dynamics Mediated by Mitofusin 1 Is Required for POMC Neuron Glucose-Sensing and Insulin Release Control.Apelin stimulates both cholecystokinin and glucagon-like peptide 1 secretions in vitro and in vivo in rodents.Hedgehog partial agonism drives Warburg-like metabolism in muscle and brown fat.Brain glucagon-like peptide-1 increases insulin secretion and muscle insulin resistance to favor hepatic glycogen storage.Apelin Controls Fetal and Neonatal Glucose Homeostasis and Is Altered by Maternal Undernutrition.p53-PGC-1α pathway mediates oxidative mitochondrial damage and cardiomyocyte necrosis induced by monoamine oxidase-A upregulation: role in chronic left ventricular dysfunction in mice.Peroxisome proliferator-activated receptor-alpha-null mice have increased white adipose tissue glucose utilization, GLUT4, and fat mass: Role in liver and brain.Evidence for a spontaneous nitric oxide release from the rat median eminence: influence on gonadotropin-releasing hormone release.Variation of endothelial nitric oxide synthase synthesis in the median eminence during the rat estrous cycle: an additional argument for the implication of vascular blood vessel in the control of GnRH release.The apelinergic system: sexual dimorphism and tissue-specific modulations by obesity and insulin resistance in female mice.Intracerebroventricular infusion of glucose, insulin, and the adenosine monophosphate-activated kinase activator, 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside, controls muscle glycogen synthesis.Brain glucagon-like peptide 1 signaling controls the onset of high-fat diet-induced insulin resistance and reduces energy expenditure.Liver-specific deletion of insulin receptor substrate 2 does not impair hepatic glucose and lipid metabolism in mice.Targeted deletion of AIF decreases mitochondrial oxidative phosphorylation and protects from obesity and diabetes.
P50
Q24562990-1938CC71-D190-49DF-9E10-EFD50D42338EQ27025069-BFEB14EF-A02B-4A54-982B-807FC92270BDQ27316188-42AB902A-BA22-486C-9622-533A0FC82F04Q28077145-1EEB3CD9-221C-428D-8D70-6466D8FECF1EQ28302298-4E1AB001-B2A1-4078-8E46-946C9E1540D0Q28583358-42C5F006-164C-4B13-AEE9-EF7A7D04EE5FQ30492859-A0B377CA-57B5-4CF3-B74E-80B6CDBE2543Q33464957-9360443A-3D88-4132-A7B7-675504497689Q34006689-DC8A1AED-A91B-4825-81C1-FAB3252281E7Q34092765-FEEA335F-D8E5-4BBE-BD9A-AC119F3CA198Q34615377-DB36BE8E-68DE-492A-89D0-D9B280389735Q34866320-1E86DDEF-8194-4091-87B5-021E7A6A8E36Q34880427-E4FC091E-D783-4B60-A2E2-9E6E1BB741C6Q35114027-866ECD03-E463-4283-A710-90A1EEF32600Q35114807-0F520E79-1C90-498E-8846-9444D101BF62Q36254873-F8034741-69B6-43B1-87A3-588991A36B32Q36902266-E16E594F-1BE8-4829-BE18-F10F018C9AA3Q36906311-F2E78BE2-7987-4DCC-B509-BB4FB54FAF29Q37221764-65627BD4-FC23-42A7-9594-29168519E920Q37513099-2A8F68F7-F90E-4486-8179-1FE910FBCCB5Q37617075-0403059B-E8BE-42CA-A567-8B8D95988186Q37727703-BE523767-1466-4065-9507-9CC7F7FD1B49Q37897155-158CD608-1B56-49DD-9CAE-8C0D07A7D051Q37996726-858C749E-B290-4630-9BCE-FEC318BB052AQ38129358-DF4ADA3D-679A-48FF-859D-714F69E1E97AQ38501605-A1527A1D-F5DF-49A3-904F-0F8686EAE842Q38737980-7870FC60-2EDA-4F87-9CC2-979A78D000D5Q39108924-9B4E4C73-D611-43A6-82FF-C3937A71C0F0Q39260254-3DD8BB01-7CD3-4599-8B02-4A737E85AC11Q40035788-BBF1DA28-19DE-40E0-828D-096640AAA43FQ40247756-27DBE7DB-BAF7-461F-B38E-566D391DDE6AQ41673217-03EB954F-BEE8-45E0-AFC4-482EF5CDC723Q43527110-1E1C27BB-C4C2-4E51-866A-0B10A73575CEQ43610620-69476074-7C25-42CF-A7F9-25B9B69F1462Q43743241-AE060998-8D8A-4775-A68A-636D8974C9BEQ44102750-15051235-69DE-4291-85FD-120CE04A0B81Q44932523-F06BE6BA-BFE2-4597-A326-2B157B3DEFAAQ46538045-1E99603A-DF5D-4D5C-A321-0D50D3F933D8Q46888113-8D7DE769-DD64-4FAC-AC1F-988627A7CF32Q46915798-0AA95BF8-4011-48B4-B344-75582F1F0A9A
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Claude Knauf
@ast
Claude Knauf
@en
Claude Knauf
@es
Claude Knauf
@nl
Claude Knauf
@sl
type
label
Claude Knauf
@ast
Claude Knauf
@en
Claude Knauf
@es
Claude Knauf
@nl
Claude Knauf
@sl
prefLabel
Claude Knauf
@ast
Claude Knauf
@en
Claude Knauf
@es
Claude Knauf
@nl
Claude Knauf
@sl
P106
P21
P31
P496
0000-0001-5213-5378